154 related articles for article (PubMed ID: 30179443)
41. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system.
Yu F; Wu H; Tang Y; Xu Y; Qian X; Zhu W
Int J Pharm; 2018 Jan; 536(1):11-20. PubMed ID: 29146540
[TBL] [Abstract][Full Text] [Related]
42. Two-dimensional magnetic WS2@Fe3O4 nanocomposite with mesoporous silica coating for drug delivery and imaging-guided therapy of cancer.
Yang G; Gong H; Liu T; Sun X; Cheng L; Liu Z
Biomaterials; 2015 Aug; 60():62-71. PubMed ID: 25985153
[TBL] [Abstract][Full Text] [Related]
43. Targeted Diagnosis, Therapeutic Monitoring, and Assessment of Atherosclerosis Based on Mesoporous Silica Nanoparticles Coated with cRGD-Platelets.
Zhang W; Lv Z; Zhang Y; Gopinath SCB; Yuan Y; Huang D; Miao L
Oxid Med Cell Longev; 2022; 2022():6006601. PubMed ID: 36211824
[TBL] [Abstract][Full Text] [Related]
44. Multifunctional magnetic silica nanotubes for MR imaging and targeted drug delivery.
Huang L; Ao L; Wang W; Hu D; Sheng Z; Su W
Chem Commun (Camb); 2015 Mar; 51(18):3923-6. PubMed ID: 25656155
[TBL] [Abstract][Full Text] [Related]
45. Tumor acidity-activatable manganese phosphate nanoplatform for amplification of photodynamic cancer therapy and magnetic resonance imaging.
Hao Y; Zheng C; Wang L; Zhang J; Niu X; Song Q; Feng Q; Zhao H; Li L; Zhang H; Zhang Z; Zhang Y
Acta Biomater; 2017 Oct; 62():293-305. PubMed ID: 28842332
[TBL] [Abstract][Full Text] [Related]
46. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
47. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells.
Kim T; Momin E; Choi J; Yuan K; Zaidi H; Kim J; Park M; Lee N; McMahon MT; Quinones-Hinojosa A; Bulte JW; Hyeon T; Gilad AA
J Am Chem Soc; 2011 Mar; 133(9):2955-61. PubMed ID: 21314118
[TBL] [Abstract][Full Text] [Related]
48. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery.
Shin J; Anisur RM; Ko MK; Im GH; Lee JH; Lee IS
Angew Chem Int Ed Engl; 2009; 48(2):321-4. PubMed ID: 19040234
[No Abstract] [Full Text] [Related]
49. A novel anti-VEGF targeting and MRI-visible smart drug delivery system for specific diagnosis and therapy of liver cancer.
Huang H; Li Y; Li C; Wang Y; Sun Y; Wang J
Macromol Biosci; 2013 Oct; 13(10):1358-68. PubMed ID: 23852809
[TBL] [Abstract][Full Text] [Related]
50. Zwitterion-Coated Ultrasmall MnO Nanoparticles Enable Highly Sensitive
Wei R; Liu K; Zhang K; Fan Y; Lin H; Gao J
ACS Appl Mater Interfaces; 2022 Jan; 14(3):3784-3791. PubMed ID: 35019261
[TBL] [Abstract][Full Text] [Related]
51. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy.
Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L
Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341
[TBL] [Abstract][Full Text] [Related]
52. Intracellular antioxidants dissolve man-made antioxidant nanoparticles: using redox vulnerability of nanoceria to develop a responsive drug delivery system.
Muhammad F; Wang A; Qi W; Zhang S; Zhu G
ACS Appl Mater Interfaces; 2014; 6(21):19424-33. PubMed ID: 25312332
[TBL] [Abstract][Full Text] [Related]
53. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
[TBL] [Abstract][Full Text] [Related]
54. Manganese dioxide nanosheets-based redox/pH-responsive drug delivery system for cancer theranostic application.
Hao Y; Wang L; Zhang B; Li D; Meng D; Shi J; Zhang H; Zhang Z; Zhang Y
Int J Nanomedicine; 2016; 11():1759-78. PubMed ID: 27199556
[TBL] [Abstract][Full Text] [Related]
55. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
[TBL] [Abstract][Full Text] [Related]
56. Silica-F127 nanohybrid-encapsulated manganese oxide nanoparticles for optimized T1 magnetic resonance relaxivity.
Wei Hsu BY; Wang M; Zhang Y; Vijayaragavan V; Wong SY; Yuang-Chi Chang A; Bhakoo KK; Li X; Wang J
Nanoscale; 2014 Jan; 6(1):293-9. PubMed ID: 24193096
[TBL] [Abstract][Full Text] [Related]
57. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
[TBL] [Abstract][Full Text] [Related]
58. Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications.
Ling D; Lee N; Hyeon T
Acc Chem Res; 2015 May; 48(5):1276-85. PubMed ID: 25922976
[TBL] [Abstract][Full Text] [Related]
59. Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells.
Liu HM; Wu SH; Lu CW; Yao M; Hsiao JK; Hung Y; Lin YS; Mou CY; Yang CS; Huang DM; Chen YC
Small; 2008 May; 4(5):619-26. PubMed ID: 18491363
[TBL] [Abstract][Full Text] [Related]
60. Macrophage entrapped silica coated superparamagnetic iron oxide particles for controlled drug release in a 3D cancer model.
Ullah S; Seidel K; Türkkan S; Warwas DP; Dubich T; Rohde M; Hauser H; Behrens P; Kirschning A; Köster M; Wirth D
J Control Release; 2019 Jan; 294():327-336. PubMed ID: 30586597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]